SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 63 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $24,000 | -40.0% | 43,608 | -40.1% | 0.00% | – |
| Q1 2016 | $40,000 | -41.2% | 72,822 | -3.9% | 0.00% | – |
| Q4 2015 | $68,000 | -64.8% | 75,792 | -68.4% | 0.00% | – |
| Q3 2015 | $193,000 | -86.2% | 239,711 | -48.4% | 0.00% | – |
| Q2 2015 | $1,398,000 | -7.7% | 464,448 | -24.9% | 0.00% | -100.0% |
| Q1 2015 | $1,514,000 | -41.1% | 618,034 | -38.7% | 0.00% | 0.0% |
| Q4 2014 | $2,572,000 | +1107.5% | 1,008,598 | +3288.2% | 0.00% | – |
| Q3 2014 | $213,000 | -19.9% | 29,768 | -27.3% | 0.00% | – |
| Q2 2014 | $266,000 | +454.2% | 40,963 | +465.2% | 0.00% | – |
| Q1 2014 | $48,000 | -85.1% | 7,247 | -89.3% | 0.00% | – |
| Q4 2013 | $322,000 | +373.5% | 68,003 | +399.2% | 0.00% | – |
| Q3 2013 | $68,000 | -59.8% | 13,622 | -58.2% | 0.00% | – |
| Q2 2013 | $169,000 | – | 32,592 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
| RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
| GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
| Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
| DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
| Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
| Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
| Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
| EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |